Product Information
LIDOCAINE 5% PATCH is a generic product labeled by Actavis Pharma, Inc., priced at $1.9978 per EA under NDC 00591352530. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 23, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00591352530
Classification
Generic
Dosage Form
PATCH
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINEApproval Type
Generic (ANDA)
FDA Application
ANDA200675FDA Approved
8/23/2012
TE Code
AB
On Market Since
9/15/2013
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 5% PATCH has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 72.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9978 per EA |
|---|---|
| All-time high | $7.3179 (Apr 16, 2014) |
| All-time low | $1.7004 (Apr 17, 2024) |
| 52-week high | $2.1180 |
| 52-week low | $1.9204 |
| Median price | $2.5572 |
| Average price | $3.1166 |
| Largest weekly change | +15.1% (May 22, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 5% PATCH?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 5% PATCH, manufactured by Actavis Pharma, Inc., is $1.9978 per EA (NDC 00591352530), effective Sep 30, 2026.
How has the price of LIDOCAINE 5% PATCH changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 5% PATCH has declined 72.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 5% PATCH?
Since Nov 28, 2013, the NADAC for LIDOCAINE 5% PATCH has ranged from a low of $1.7004 (Apr 17, 2024) to a high of $7.3179 (Apr 16, 2014), with a median of $2.5572 per EA.
Are there cheaper alternatives to LIDOCAINE 5% PATCH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIDACAINE II 5% PATCH, is $1.9418 per EA — about 3% below LIDOCAINE 5% PATCH.
Who manufactures LIDOCAINE 5% PATCH?
LIDOCAINE 5% PATCH (NDC 00591352530) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.